يعرض 141 - 160 نتائج من 29,211 نتيجة بحث عن '(((( 19 p decrease ) OR ( 50 ms decrease ))) OR ( 50 ((ng decrease) OR (mean decrease)) ))', وقت الاستعلام: 0.52s تنقيح النتائج
  1. 141
  2. 142
  3. 143
  4. 144

    Inclusion of TPP side chains result in decreased melanoma cell mitochondria membrane potential, oxygen consumption, and increased DHE oxidation. حسب Kyle C. Kloepping (9928265)

    منشور في 2020
    "…The error bars for all data presented in Fig 3 represent the mean ± SEM. Results demonstrate that TPP derivatives preferentially accumulate in mitochondria; decrease mitochondria membrane potential and ATP-linked oxygen consumption; and increase DHE oxidation. …"
  5. 145
  6. 146

    ngLVA degradation kinetics. حسب Nicole A. Grieshaber (11175417)

    منشور في 2022
    "…The infections were monitored using live cell imaging for 50 hours. Expression intensities from >50 individual inclusions were measured via automated live-cell fluorescence microscopy and the mean intensities are shown. …"
  7. 147

    DART-ID decreases missing datapoints across runs. حسب Albert Tian Chen (6900215)

    منشور في 2019
    "…Only peptides seen in >50% of experiments are included. (<b>b</b>) Decrease in missing data across all runs after applying DART-ID, for SCoPE-MS and the two bulk sets from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007082#pcbi.1007082.g004" target="_blank">Fig 4</a> at 1% FDR. …"
  8. 148
  9. 149
  10. 150

    COVID19 effect on essential services. حسب Admas Abera (11821659)

    منشور في 2024
    "…The present study found that the mean number of patients treated for TB declined by 35 patients (β: -34.62; 95%CI: -50.29, -18.95) compared to the pre-COVID-19 era while the number of new patients enrolled for ART decreased by 71 patients (β: -70.62; 95%CI: -107.19, -34.05). …"
  11. 151
  12. 152
  13. 153
  14. 154
  15. 155
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160

    Annual treatment frequencies in all eyes. حسب Yasuyuki Sotani (20114144)

    منشور في 2025
    "…<p>The number of anti-VEGF treatments, STTA, MA-PC, PPV, and total treatments (mean ± SD) significantly decreased from 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, 0.1 ± 0.3, and 3.7 ± 1.7 preoperatively to 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at year 2 to 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at year 3 to 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …"